146 related articles for article (PubMed ID: 11700264)
1. Population colorectal cancer screening with fecal occult blood test.
Rennert G; Rennert HS; Miron E; Peterburg Y
Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
[TBL] [Abstract][Full Text] [Related]
2. Detecting colorectal cancer with a large scale fecal occult blood testing program.
Gregorio DI; Lolachi P; Hansen H
Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
[TBL] [Abstract][Full Text] [Related]
3. [Screening for colorectal tumors using fecal occult blood studies].
Restellini A; Margalith D; Bauerfeind P; Guyot J; Ollyo JB; Gonvers JJ; Blum AL
Ther Umsch; 1989 Jun; 46(6):389-97. PubMed ID: 2667190
[TBL] [Abstract][Full Text] [Related]
4. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
McGarrity TJ; Long PA; Peiffer LP
Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia.
Yoshinaga M; Motomura S; Takeda H; Yanagisawa Z; Ikeda K
Am J Gastroenterol; 1995 Jul; 90(7):1076-9. PubMed ID: 7611200
[TBL] [Abstract][Full Text] [Related]
6. [Screening for colorectal neoplasms].
Shani A; Rozen P; Fink A; Bass D; Levy E; Fireman Z; Gottesfeld F; Baker S; Fraizer D; Bentwich Z
Harefuah; 1990 Jan; 118(2):66-70. PubMed ID: 2179072
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
Nakama H; Kamijo N
Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
[TBL] [Abstract][Full Text] [Related]
8. [Screening for colorectal cancer and polyps].
Krieger Y; Fraser D; Odes HS; Krugliak P; Fraser GM
Harefuah; 1992 Mar; 122(6):354-6, 408. PubMed ID: 1582622
[TBL] [Abstract][Full Text] [Related]
9. [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].
Hofbauer F; Mach K; Egermann G
Wien Klin Wochenschr; 1991; 103(10):288-95. PubMed ID: 1858377
[TBL] [Abstract][Full Text] [Related]
10. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.
Mandel JS; Bond JH; Church TR; Snover DC; Bradley GM; Schuman LM; Ederer F
N Engl J Med; 1993 May; 328(19):1365-71. PubMed ID: 8474513
[TBL] [Abstract][Full Text] [Related]
11. [The role of and suitability of the occult fecal blood test in a preventive program for colorectal carcinoma].
Ebling Z; Hadzić N
Lijec Vjesn; 1989 Dec; 111(12):432-6. PubMed ID: 2636303
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Shams' test for rectal mucus to an immunological test for fecal occult blood in large intestinal carcinoma screening. Analysis of a check-up of 6480 asymptomatic subjects.
Zhou DY; Feng FC; Zhang YL; Lai ZS; Zhang WD; Li LB; Xu GL; Wan TM; Pan DS; Zhou D
Chin Med J (Engl); 1993 Oct; 106(10):739-42. PubMed ID: 8033605
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
14. [Fecal occult blood test and mass screening for colorectal cancer].
Saito H; Soma Y; Kawaguchi H
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2232-40. PubMed ID: 1929443
[TBL] [Abstract][Full Text] [Related]
15. Mass screening for colorectal cancer by testing for occult blood under restricted diet and a questionnaire in Osaka.
Fujita M; Nakano Y; Ohta J; Kumanishi Y; Taguchi T
Cancer Detect Prev; 1987; 10(5-6):353-60. PubMed ID: 3568034
[TBL] [Abstract][Full Text] [Related]
16. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
Macrae FA; St John DJ
Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of fecal occult blood screening in automated multiphasic health testing and services.
Nishikawa A; Okuda T; Kubota I; Azuma H; Tanaka T; Koyasu T; Kumazaki N; Iwata H; Tanaka T; Kato K
Jpn J Clin Oncol; 1987 Jun; 17(2):107-12. PubMed ID: 3613137
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of colorectal carcinomas detected by mass screening].
Kikkawa N; Tsuchiya Y; Matsui S; Murai M; Yamamoto H; Matsui K
Gan No Rinsho; 1989 Jul; 35(8):923-6. PubMed ID: 2746866
[TBL] [Abstract][Full Text] [Related]
19. Fecal occult blood testing for colorectal cancer in an ethnically diverse population.
Glober GA; Hundahl S; Stucke J; Choy M
West J Med; 1994 Oct; 161(4):377-82. PubMed ID: 7817548
[TBL] [Abstract][Full Text] [Related]
20. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
Adamsen S; Kronborg O
Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]